Longaeva Partners »

Arrowhead Pharmaceuticals shares owned by Longaeva Partners

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $12M 195k 62.70

More positions owned by Longaeva Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation Call Option (BSX)
Bank of America Corporation (BAC)
NVIDIA Corporation Call Option (NVDA)
PNC Financial Services (PNC)
Key (KEY)
Goldman Sachs (GS)
Morgan Stanley Com New (MS)
Minimed Group
Citizens Financial (CFG)
Evercore Class A (EVR)
Mastercard Incorporated Cl A (MA)
Msci (MSCI)
S&p Global (SPGI)
Us Bancorp Com New (USB)

View all positions for Longaeva Partners

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
Vanguard Portfolio Management
FMR
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Fred Alger Management
Invesco
Slate Path Capital
Vestal Point Capital
Arrowstreet Capital, Limited Partnership
Baker Bros. Advisors
Driehaus Capital Management

View all funds holding Arrowhead Pharmaceuticals